Abstract
G-protein-coupled receptors (GPCRs) represent the main family of cell surface receptors and are virtually expressed in all eukaryotic cells. Interestingly, a large number of clinically used drugs exert their pharmacological effect via a GPCR, thus it seems crucial to deeply understand the biology of these receptors. The study of GPCR activation and signaling has been classically performed by physiological, biochemical and pharmacological approaches using radioactivity-based tools. However, apart from the potential hazards of radioisotope handling and environmental burden, these approaches have some technical limitations. Therefore, the development of fluorescence-based techniques in general and fluorescence and bioluminescence resonance energy transfer (FRET and BRET) in particular have revolutionized the way to study GPCR functioning both in vitro and in vivo. Indeed, these techniques allow the characterization and visualization of all the individual GPCR signaling steps (i.e. ligand binding, receptor activation, G-protein coupling, G-protein activation, GPCR desensitization) with high temporal and spatial resolution. Here, we review the use and impact of fluorescent-based methodologies on the deciphering of GPCR biology.
Keywords: BRET, FRET, G protein-coupled receptor, ligand-receptor interaction, protein-protein interaction.
Current Pharmaceutical Biotechnology
Title:Deciphering G Protein-Coupled Receptor Biology with Fluorescence-based Methods
Volume: 15 Issue: 10
Author(s): Francisco Ciruela, Antoni Vallano, Maria L. Cuffi, Lourdes Carbonell, Silvia Sanchez, Josep M. Arnau, Carla Tasca, Victor Fernandez-Duenas and Maricel Gomez-Soler
Affiliation:
Keywords: BRET, FRET, G protein-coupled receptor, ligand-receptor interaction, protein-protein interaction.
Abstract: G-protein-coupled receptors (GPCRs) represent the main family of cell surface receptors and are virtually expressed in all eukaryotic cells. Interestingly, a large number of clinically used drugs exert their pharmacological effect via a GPCR, thus it seems crucial to deeply understand the biology of these receptors. The study of GPCR activation and signaling has been classically performed by physiological, biochemical and pharmacological approaches using radioactivity-based tools. However, apart from the potential hazards of radioisotope handling and environmental burden, these approaches have some technical limitations. Therefore, the development of fluorescence-based techniques in general and fluorescence and bioluminescence resonance energy transfer (FRET and BRET) in particular have revolutionized the way to study GPCR functioning both in vitro and in vivo. Indeed, these techniques allow the characterization and visualization of all the individual GPCR signaling steps (i.e. ligand binding, receptor activation, G-protein coupling, G-protein activation, GPCR desensitization) with high temporal and spatial resolution. Here, we review the use and impact of fluorescent-based methodologies on the deciphering of GPCR biology.
Export Options
About this article
Cite this article as:
Ciruela Francisco, Vallano Antoni, Cuffi L. Maria, Carbonell Lourdes, Sanchez Silvia, Arnau M. Josep, Tasca Carla, Fernandez-Duenas Victor and Gomez-Soler Maricel, Deciphering G Protein-Coupled Receptor Biology with Fluorescence-based Methods, Current Pharmaceutical Biotechnology 2014; 15 (10) . https://dx.doi.org/10.2174/1389201015666140909125119
DOI https://dx.doi.org/10.2174/1389201015666140909125119 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot topic: Innate Immunity Molecules S100A8/A9 Involved in Stress Response and Cancer Biology (Guest Editors: Claus Kerkhoff and Saeid Ghavami)]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Roles of Sox Family Genes in Sarcoma
Current Drug Targets Synthesis and Biological Evaluation of Novel Pyrazole Derivatives as Anti-Inflammatory Antimicrobial Agents
Medicinal Chemistry Copper Complexes as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Fetal Programming of the Human Brain: Is there a Link with Insurgence of Neurodegenerative Disorders in Adulthood?
Current Medicinal Chemistry Sesamin and Sesamolin: Natures Therapeutic Lignans
Current Enzyme Inhibition Bifunctional siRNA Containing Immunostimulatory Motif Enhances Protection Against Pandemic H1N1 Virus Infection
Current Gene Therapy Multifunctional Antimicrobial Proteins and Peptides: Natural Activators of Immune Systems
Current Pharmaceutical Design May Adjuvant Therapy Play A Role for the Management of Renal Cell Carcinoma? A Review of Literature and Ongoing Trials
Anti-Cancer Agents in Medicinal Chemistry Metabolic Syndrome and Adipose Tissue: New Clinical Aspects and Therapeutic Targets
Current Pharmaceutical Design Small Molecules Modulating Biogenesis or Processing of microRNAs with Therapeutic Potentials
Current Medicinal Chemistry Bioactive Cyclohexenones: A Mini Review
Current Bioactive Compounds Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy
Current Medicinal Chemistry Machine Intelligence Techniques for the Identification and Diagnosis of COVID-19
Current Medicinal Chemistry Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome
Current Cancer Drug Targets Extracellular Vesicles and Insulin Resistance: A Potential Interaction in Vascular Dysfunction
Current Vascular Pharmacology N-glycosylation Engineering of Biopharmaceutical Expression Systems
Current Molecular Medicine EDITORIAL (Thematic Issue: Emerging Roles of Epithelial-to-Mesenchymal Transition in Tumorigenesis)
Current Cancer Drug Targets Clopidogrel-Proton Pump Inhibitor Interaction: A Primer for Clinicians
Cardiovascular & Hematological Disorders-Drug Targets Vaccines for Cytomegalovirus
Infectious Disorders - Drug Targets